Amit Sachdev Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amit Sachdev.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amit Sachdev. Amit Sachdev is EVP, Chief Patient Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CRO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, Policy, Access & Value in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Corp Affairs & Pub Policy in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Public Policy,Gov Affairs in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR).
Latest Insider Trading Transactions of Amit Sachdev
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 3,884 | 336,044 | 0 | |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 217.69 | 200 | 43,538 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 216.67 | 1,338 | 289,904 | 40,333 | 41.7 K to 40.3 K (-3.21 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.58 | 2,346 | 505,751 | 41,671 | 44 K to 41.7 K (-5.33 %) |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 3,884 | 336,044 | 44,017 | 40.1 K to 44 K (+9.68 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 216.62 | 200 | 43,324 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.56 | 336 | 72,428 | 40,333 | 40.7 K to 40.3 K (-0.83 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 214.19 | 668 | 143,079 | 40,669 | 41.3 K to 40.7 K (-1.62 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 213.30 | 1,460 | 311,418 | 41,337 | 42.8 K to 41.3 K (-3.41 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 211.56 | 922 | 195,058 | 42,797 | 43.7 K to 42.8 K (-2.11 %) |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 217.57 | 2,946 | 640,961 | 43,719 | 46.7 K to 43.7 K (-6.31 %) |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 213.02 | 800 | 170,416 | 46,665 | 47.5 K to 46.7 K (-1.69 %) |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 212.15 | 5,800 | 1,230,470 | 47,465 | 53.3 K to 47.5 K (-10.89 %) |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 211.36 | 1,500 | 317,040 | 53,265 | 54.8 K to 53.3 K (-2.74 %) |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 210.00 | 1,164 | 244,440 | 54,765 | 55.9 K to 54.8 K (-2.08 %) |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 211.75 | 7,613 | 1,612,053 | 55,929 | 63.5 K to 55.9 K (-11.98 %) |
Feb 12 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 214.16 | 2,421 | 518,481 | 68,002 | 70.4 K to 68 K (-3.44 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 11,627 | 0 | 70,423 | 58.8 K to 70.4 K (+19.78 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,324 | 0 | 58,796 | 48.5 K to 58.8 K (+21.30 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,126 | 0 | 48,472 | 38.3 K to 48.5 K (+26.41 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Gift | G | 0.00 | 3,391 | 0 | 7,368 | 10.8 K to 7.4 K (-31.52 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 11,627 | 0 | 70,423 | 58.8 K to 70.4 K (+19.78 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,324 | 0 | 58,796 | 48.5 K to 58.8 K (+21.30 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,126 | 0 | 48,472 | 38.3 K to 48.5 K (+26.41 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Gift | G | 0.00 | 3,391 | 0 | 7,368 | 10.8 K to 7.4 K (-31.52 %) |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 224.44 | 8 | 1,796 | 35,103 | 35.1 K to 35.1 K (-0.02 %) |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 223.76 | 22 | 4,923 | 35,111 | 35.1 K to 35.1 K (-0.06 %) |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 222.50 | 12 | 2,670 | 35,133 | 35.1 K to 35.1 K (-0.03 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 3,884 | |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.18 | 751 | 209,664 | 35,103 | 35.9 K to 35.1 K (-2.09 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 278.25 | 690 | 191,993 | 35,854 | 36.5 K to 35.9 K (-1.89 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.96 | 500 | 138,480 | 36,544 | 37 K to 36.5 K (-1.35 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 37,044 | 35.1 K to 37 K (+5.53 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 3,884 | |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.18 | 751 | 209,664 | 35,103 | 35.9 K to 35.1 K (-2.09 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 278.25 | 690 | 191,993 | 35,854 | 36.5 K to 35.9 K (-1.89 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.96 | 500 | 138,480 | 36,544 | 37 K to 36.5 K (-1.35 %) |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 37,044 | 35.1 K to 37 K (+5.53 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 10,665 | 1,406,607 | 0 | |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 286.72 | 100 | 28,672 | 35,103 | 35.2 K to 35.1 K (-0.28 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 285.94 | 1,367 | 390,880 | 35,203 | 36.6 K to 35.2 K (-3.74 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 285.15 | 2,314 | 659,837 | 36,570 | 38.9 K to 36.6 K (-5.95 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 283.98 | 1,100 | 312,378 | 38,884 | 40 K to 38.9 K (-2.75 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 282.89 | 913 | 258,279 | 39,984 | 40.9 K to 40 K (-2.23 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 281.74 | 1,398 | 393,873 | 40,897 | 42.3 K to 40.9 K (-3.31 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 280.77 | 1,817 | 510,159 | 42,295 | 44.1 K to 42.3 K (-4.12 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.67 | 655 | 183,184 | 44,112 | 44.8 K to 44.1 K (-1.46 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 277.38 | 201 | 55,753 | 44,767 | 45 K to 44.8 K (-0.45 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.25 | 800 | 221,000 | 44,968 | 45.8 K to 45 K (-1.75 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 10,665 | 1,406,607 | 45,768 | 35.1 K to 45.8 K (+30.38 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 669 | 88,234 | 10,665 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 275.28 | 669 | 184,162 | 35,103 | 35.8 K to 35.1 K (-1.87 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 669 | 88,234 | 35,772 | 35.1 K to 35.8 K (+1.91 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 13,356 | 1,761,523 | 11,334 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 13,356 | 1,761,523 | 11,334 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 5,825 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 5,825 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 9,310 | 1,227,896 | 24,690 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 9,310 | 1,227,896 | 24,690 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 32,500 | 3,547,050 | 0 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 32,500 | 3,547,050 | 0 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 273.59 | 200 | 54,718 | 35,103 | 35.3 K to 35.1 K (-0.57 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 273.59 | 200 | 54,718 | 35,103 | 35.3 K to 35.1 K (-0.57 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 272.58 | 403 | 109,850 | 35,303 | 35.7 K to 35.3 K (-1.13 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 272.58 | 403 | 109,850 | 35,303 | 35.7 K to 35.3 K (-1.13 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 271.09 | 100 | 27,109 | 35,706 | 35.8 K to 35.7 K (-0.28 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 271.09 | 100 | 27,109 | 35,706 | 35.8 K to 35.7 K (-0.28 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 270.01 | 11,553 | 3,119,426 | 35,806 | 47.4 K to 35.8 K (-24.39 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 270.01 | 11,553 | 3,119,426 | 35,806 | 47.4 K to 35.8 K (-24.39 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 269.08 | 700 | 188,356 | 47,359 | 48.1 K to 47.4 K (-1.46 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 269.08 | 700 | 188,356 | 47,359 | 48.1 K to 47.4 K (-1.46 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 267.34 | 300 | 80,202 | 48,059 | 48.4 K to 48.1 K (-0.62 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 267.34 | 300 | 80,202 | 48,059 | 48.4 K to 48.1 K (-0.62 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 265.72 | 100 | 26,572 | 48,359 | 48.5 K to 48.4 K (-0.21 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 265.72 | 100 | 26,572 | 48,359 | 48.5 K to 48.4 K (-0.21 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 13,356 | 1,761,523 | 48,459 | 35.1 K to 48.5 K (+38.05 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 13,356 | 1,761,523 | 48,459 | 35.1 K to 48.5 K (+38.05 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 264.92 | 12,940 | 3,428,065 | 35,103 | 48 K to 35.1 K (-26.93 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 264.92 | 12,940 | 3,428,065 | 35,103 | 48 K to 35.1 K (-26.93 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 263.58 | 964 | 254,091 | 48,043 | 49 K to 48 K (-1.97 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 263.58 | 964 | 254,091 | 48,043 | 49 K to 48 K (-1.97 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 262.69 | 9,447 | 2,481,632 | 49,007 | 58.5 K to 49 K (-16.16 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 262.69 | 9,447 | 2,481,632 | 49,007 | 58.5 K to 49 K (-16.16 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 261.68 | 4,395 | 1,150,084 | 58,454 | 62.8 K to 58.5 K (-6.99 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 261.68 | 4,395 | 1,150,084 | 58,454 | 62.8 K to 58.5 K (-6.99 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 260.48 | 8,383 | 2,183,604 | 62,849 | 71.2 K to 62.8 K (-11.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 260.48 | 8,383 | 2,183,604 | 62,849 | 71.2 K to 62.8 K (-11.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 259.63 | 6,223 | 1,615,677 | 71,232 | 77.5 K to 71.2 K (-8.03 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 259.63 | 6,223 | 1,615,677 | 71,232 | 77.5 K to 71.2 K (-8.03 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 258.59 | 1,400 | 362,026 | 77,455 | 78.9 K to 77.5 K (-1.78 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 258.59 | 1,400 | 362,026 | 77,455 | 78.9 K to 77.5 K (-1.78 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 78,855 | 76.9 K to 78.9 K (+2.52 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 78,855 | 76.9 K to 78.9 K (+2.52 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 9,310 | 1,227,896 | 76,913 | 67.6 K to 76.9 K (+13.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 9,310 | 1,227,896 | 76,913 | 67.6 K to 76.9 K (+13.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 32,500 | 3,547,050 | 67,603 | 35.1 K to 67.6 K (+92.58 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 32,500 | 3,547,050 | 67,603 | 35.1 K to 67.6 K (+92.58 %) |
Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 238.33 | 540 | 128,698 | 32,915 | 33.5 K to 32.9 K (-1.61 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 236.63 | 180 | 42,593 | 33,455 | 33.6 K to 33.5 K (-0.54 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 235.75 | 360 | 84,870 | 33,635 | 34 K to 33.6 K (-1.06 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 234.56 | 533 | 125,020 | 33,995 | 34.5 K to 34 K (-1.54 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 233.18 | 90 | 20,986 | 34,528 | 34.6 K to 34.5 K (-0.26 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.62 | 450 | 104,679 | 34,618 | 35.1 K to 34.6 K (-1.28 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.98 | 270 | 62,365 | 35,068 | 35.3 K to 35.1 K (-0.76 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.00 | 953 | 219,190 | 35,338 | 36.3 K to 35.3 K (-2.63 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 239.23 | 3,156 | 755,010 | 36,291 | 39.4 K to 36.3 K (-8.00 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.82 | 249 | 61,209 | 39,447 | 39.7 K to 39.4 K (-0.63 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.15 | 720 | 176,508 | 39,696 | 40.4 K to 39.7 K (-1.78 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 244.08 | 540 | 131,803 | 40,416 | 41 K to 40.4 K (-1.32 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 242.85 | 1,260 | 305,991 | 40,956 | 42.2 K to 41 K (-2.98 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 242.04 | 720 | 174,269 | 42,216 | 42.9 K to 42.2 K (-1.68 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 241.50 | 3,262 | 787,773 | 42,936 | 46.2 K to 42.9 K (-7.06 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 248.73 | 400 | 99,492 | 46,198 | 46.6 K to 46.2 K (-0.86 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 247.98 | 2,103 | 521,502 | 46,598 | 48.7 K to 46.6 K (-4.32 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 246.88 | 1,821 | 449,568 | 48,701 | 50.5 K to 48.7 K (-3.60 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.99 | 4,320 | 1,062,677 | 50,522 | 54.8 K to 50.5 K (-7.88 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.05 | 3,426 | 839,541 | 54,842 | 58.3 K to 54.8 K (-5.88 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 243.53 | 1,000 | 243,530 | 58,268 | 59.3 K to 58.3 K (-1.69 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 240.95 | 12,215 | 2,943,204 | 59,268 | 71.5 K to 59.3 K (-17.09 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,323 | 0 | 71,483 | 61.2 K to 71.5 K (+16.88 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 9,800 | 0 | 61,160 | 51.4 K to 61.2 K (+19.08 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 15,170 | 0 | 51,360 | 36.2 K to 51.4 K (+41.92 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 7,767 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,156 | 196,304 | 0 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.87 | 400 | 93,148 | 36,190 | 36.6 K to 36.2 K (-1.09 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.92 | 1,177 | 272,970 | 36,590 | 37.8 K to 36.6 K (-3.12 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.25 | 1,306 | 302,013 | 37,767 | 39.1 K to 37.8 K (-3.34 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.07 | 714 | 164,270 | 39,073 | 39.8 K to 39.1 K (-1.79 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 228.89 | 500 | 114,445 | 39,787 | 40.3 K to 39.8 K (-1.24 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 40,287 | 38.3 K to 40.3 K (+5.06 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,156 | 196,304 | 38,346 | 36.2 K to 38.3 K (+5.96 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 7,767 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,156 | 196,304 | 0 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.87 | 400 | 93,148 | 36,190 | 36.6 K to 36.2 K (-1.09 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.92 | 1,177 | 272,970 | 36,590 | 37.8 K to 36.6 K (-3.12 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.25 | 1,306 | 302,013 | 37,767 | 39.1 K to 37.8 K (-3.34 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.07 | 714 | 164,270 | 39,073 | 39.8 K to 39.1 K (-1.79 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 228.89 | 500 | 114,445 | 39,787 | 40.3 K to 39.8 K (-1.24 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 40,287 | 38.3 K to 40.3 K (+5.06 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,156 | 196,304 | 38,346 | 36.2 K to 38.3 K (+5.96 %) |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 32,500 | |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 235.00 | 5,000 | 1,175,000 | 36,190 | 41.2 K to 36.2 K (-12.14 %) |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 41,190 | 36.2 K to 41.2 K (+13.82 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 37,500 | |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.00 | 5,000 | 1,150,000 | 36,190 | 41.2 K to 36.2 K (-12.14 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 41,190 | 36.2 K to 41.2 K (+13.82 %) |